← Eichor
Study identifier: NCT04558164 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment

Condition: Cognitive Dysfunction · Memory Disorders in Old Age  ·  Sponsor: University of California, Los Angeles

PhaseNA
Planned participants70
Who can joinAll sexes, 55 Years to 100 Years
Healthy volunteersNo

About this study

The purpose of this study is to see if stimulation of the brain can improve memory. The investigators will use a device called transcranial magnetic stimulation that can stimulate and activate a specific part of the brain that is important for memory. The study will enroll MCI subjects and subjects with subjective memory complaints who will be randomly assigned to receive active or sham brain stimulation. 'Blinded' or 'sham-controlled' means that the subject will not know whether the treatment they receive is the active treatment or the non-active stimulation. In the 'sham' condition, the stimulator will turn on but will not actually be stimulating the target brain region.

This description comes directly from the study's public registry record.

Talk to the study team

Sonja Hiller  ·  310-210-6978  ·  suthanalab@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California Los AngelesLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04558164